Regulus Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RGLS and other ETFs, options, and stocks.

About RGLS

Regulus Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of drugs targeting microRNAs. Its two lead product candidates, RG-012 and RGLS4326, are in clinical development. 

CEO
Joseph P. Hagan
CEOJoseph P. Hagan
Employees
30
Employees30
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2007
Founded2007
Employees
30
Employees30

RGLS Key Statistics

Market cap
145.99M
Market cap145.99M
Price-Earnings ratio
-1.42
Price-Earnings ratio-1.42
Dividend yield
Dividend yield
Average volume
263.26K
Average volume263.26K
High today
$2.29
High today$2.29
Low today
$2.22
Low today$2.22
Open price
$2.29
Open price$2.29
Volume
91.74K
Volume91.74K
52 Week high
$3.79
52 Week high$3.79
52 Week low
$1.08
52 Week low$1.08
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.